<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00727012</url>
  </required_header>
  <id_info>
    <org_study_id>CS06003RG</org_study_id>
    <nct_id>NCT00727012</nct_id>
  </id_info>
  <brief_title>Multicenter International Trial Ring AnnulopLasty</brief_title>
  <acronym>MITRAL</acronym>
  <official_title>Multicenter International Trial Ring AnnulopLasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study is a multicenter, prospective non-randomized observational study without
      concurrent or matched controls in which 150 patients receiving an SJM® Rigid Saddle Ring will
      be included. The primary objective of the study is to demonstrate the effectiveness of the
      SJM® Rigid Saddle Ring when used in mitral valve repair procedures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ERO (Effective Regurgitant Orifice) in cm2 calculated with PISA method at 6 months and at patient discharge compared to baseline (pre-operative).</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NYHA class</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events rates</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Mitral Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>SJM® Rigid Saddle Ring</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The SJM® Rigid Saddle Ring is an annuloplasty ring comprised of a titanium core surrounded by a double-velour, polyester fabric sewing cuff.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mitral valve repair (SJM® Rigid Saddle Ring)</intervention_name>
    <description>mitral valve repair due to mitral degenerative or functional disease</description>
    <arm_group_label>SJM® Rigid Saddle Ring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient requiring a mitral valve repair due to mitral degenerative or functional
             disease (Note: Patients that underwent concomitant procedures, e.g. coronary artery
             bypass grafting, are eligible for this study);

          -  Patient (or legal guardian) has signed a study specific informed consent form agreeing
             to the data collection and follow-up requirements;

          -  Patients are at least 18 years old.

        Exclusion Criteria:

          -  Patient requires replacement of the aortic, tricuspid or pulmonary valve or has a
             pre-existing prosthetic valve;

          -  Patient is pregnant or nursing;

          -  Patient has active endocarditis;

          -  Patient is actively participating in another study of an investigational drug or
             device;

          -  Patients unavailable to follow-up visit (abroad residents, patients affected by
             neurological disorders...);

          -  Patients who are intravenous drug abusers, alcohol abusers, prison inmates or unable
             to give informed consent;

          -  Patients with a major non-cardiac evolving disease;

          -  Patients with a life expectancy less than 1 year;

          -  Patients are known to be noncompliant or are unlikely to complete the study;

          -  Any case in which mitral annuloplasty rings are not indicated;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raffaele De Simone, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2008</study_first_submitted>
  <study_first_submitted_qc>July 31, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2008</study_first_posted>
  <last_update_submitted>July 12, 2011</last_update_submitted>
  <last_update_submitted_qc>July 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Raffaele De Simone</name_title>
    <organization>University of Heidelberg</organization>
  </responsible_party>
  <keyword>mitral valve</keyword>
  <keyword>heart valve</keyword>
  <keyword>valve repair</keyword>
  <keyword>valve disorder</keyword>
  <keyword>valve disease</keyword>
  <keyword>cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

